Anti-C1q autoantibodies, novel tests, and clinical consequences

Frontiers in Immunology

Volumn 4, Issue MAY, 2013, Pages

  Mahler, Michael ^a   Van Schaarenburg, Rosanne A ^b   Trouw, Leendert A ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoantibody; C1Q; Complement; Diagnosis; SLE

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY;

ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC RISK; HUMAN; IMMUNOADSORPTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; PROTEIN BINDING; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY;

EID: 84883777156     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00117     Document Type: Short Survey

References (66)

1. Agnello, V., Koffler, D., Eisenberg, J. W., Winchester, R. J., and Kundel, H. G. (1971). C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J. Exp. Med. 134, 228s-241s.
2. Akhter, E., Burlingame, R. W., Seaman, A. L., Magder, L., and Petri, M. (2011). Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 20, 1267-1274.
3. Antes, U., Heinz, H. P., and Loos, M. (1988). Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 31, 457-464.
4. Berner, B., Scheel, A. K., Schettler, V., Hummel, K. M., Reuss-Borst, M. A., Muller, G. A., et al. (2001). Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann. Rheum. Dis. 60, 898-899.
5. Bigler, C., Hopfer, H., Danner, D., Schaller, M., Mihatsch, M. J., and Trendelenburg, M. (2011). Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Nephrol. Dial. Transplant. 26, 1220-1228.
6. Bigler, C., Schaller, M., Perahud, I., Osthoff, M., and Trendelenburg, M. (2009). Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J. Immunol. 183, 3512-3521.
7. Cai, X., Yang, X., Lian, F., Lin, X., Liang, M., Li, J., et al. (2010). Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J. Rheumatol. 37, 759-765.
8. Cooper, N. R. (1985). The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37, 151-216.
9. Daha, N. A., Banda, N. K., Roos, A., Beurskens, F. J., Bakker, J. M., Daha, M. R., et al. (2011). Complement activation by (auto) antibodies. Mol. Immunol. 48, 1656-1665.
10. ElGendi, S. S., and El-Sherif, W. T. (2009). Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement. Egypt. J. Immunol. 16, 135-148.
11. Feinstein, A., Munn, E. A., and Richardson, N. E. (1971). The three-dimensional conformation of M and A globulin molecules. Ann. N. Y. Acad. Sci. 190, 104-121.
12. Golan, M. D., Burger, R., and Loos, M. (1982). Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J. Immunol. 129, 445-447.
13. Grootscholten, C., Dieker, J. W., McGrath, F. D., Roos, A., Derksen, R. H., van der Vlag, J., et al. (2007). A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann. Rheum. Dis. 66, 693-696.
14. Heidenreich, U., Mayer, G., Herold, M., Klotz, W., Stempfl Al-Jazrawi, K., and Lhotta, K. (2009). Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus 18, 1276-1280.
15. Hiepe, F., Pfuller, B., Wolbart, K., Bruns, A., Leinenbach, H. P., Hepper, M., et al. (1999). C1q: a multifunctional ligand for a new immunoadsorption treatment. Ther. Apher. 3, 246-251.
16. Hogarth, M. B., Norsworthy, P. J., Allen, P. J., Trinder, P. K., Loos, M., Morley, B. J., et al. (1996). Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice. Clin. Exp. Immunol. 104, 241-246.
17. Horvath, L., Czirjak, L., Fekete, B., Jakab, L., Prohaszka, Z., Cervenak, L., et al. (2001a). Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol. Lett. 75, 103-109.
18. Horvath, L., Czirjak, L., Fekete, B., Jakab, L., Pozsonyi, T., Kalabay, L., et al. (2001b). High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin. Exp. Rheumatol. 19, 667-672.
19. Hunnangkul, S., Nitsch, D., Rhodes, B., Chadha, S., Roberton, C. A., Pessoa-Lopes, P., et al. (2008). Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis Rheum. 58, 1116-1124.
20. Julkunen, H., Ekblom-Kullberg, S., and Miettinen, A. (2012). Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol. Int. 32, 2445-2451.
21. Kalunian, K., and Joan, T. M. (2009). New directions in the treatment of systemic lupus erythematosus. Curr. Med. Res. Opin. 25, 1501-1514.
22. Kalunian, K. C., Chatham, W. W., Massarotti, E. M., Reyes-Thomas, J., Harris, C., Furie, R. A., et al. (2012). Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum. 64, 4040-4047.
23. Kohro-Kawata, J., Wener, M. H., and Mannik, M. (2002). The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J. Rheumatol. 29, 84-89.
24. Kozyro, I., Korosteleva, L., Chernoshej, D., Danner, D., Sukalo, A., and Trendelenburg, M. (2008). Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis. Clin. Immunol. 128, 409-414.
25. Mannik, M., and Wener, M. H. (1997). Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 40, 1504-1511.
26. Matrat, A., Veysseyre-Balter, C., Trolliet, P., Villar, E., Dijoud, F., Bienvenu, J., et al. (2011). Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus 20, 28-34.
27. Meyer, O. C., Nicaise-Roland, P., Cadoudal, N., Grootenboer-Mignot, S., Palazzo, E., Hayem, G., et al. (2009). Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res. Ther. 11, R87.
28. Mok, C. C., Ho, L. Y., Leung, H. W., and Wong, L. G. (2010). Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl. Res. 156, 320-325.
29. Moroni, G., Trendelenburg, M., Del, P. N., Quaglini, S., Raschi, E., Panzeri, P., et al. (2001). Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am. J. Kidney Dis. 37, 490-498.
30. Moura, C. G., Mangueira, C. L., Cruz, L. A., and Cruz, C. M. (2011). Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Nephron Clin. Pract. 118, c355-c360.
31. Norsworthy, P., and Davies, K. A. (2003). Complement components and their autoantibodies. Mol. Biotechnol. 23, 259-270.
32. Papp, K., Vegh, P., Hobor, R., Szittner, Z., Voko, Z., Podani, J., et al. (2012). Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays. PLoS ONE 7:e44824. doi:10.1371/journal.pone.0044824
33. Pfueller, B., Wolbart, K., Bruns, A., Burmester, G. R., and Hiepe, F. (2001). Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum. 44, 1962-1963.
34. Potlukova, E., Jiskra, J., Limanova, Z., Kralikova, P., Smutek, D., Mareckova, H., et al. (2008). Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease. Clin. Exp. Immunol. 153, 96-101.
35. Potlukova, E., and Kralikova, P. (2008). Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Scand. J. Immunol. 67, 423-430.
36. Pradhan, V., Rajadhyaksha, A., Mahant, G., Surve, P., Patwardhan, M., Dighe, S., et al. (2012). Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients. Indian J. Nephrol. 22, 353-357.
37. Prohaszka, Z., Daha, M. R., Susal, C., Daniel, V., Szlavik, J., Banhegyi, D., et al. (1999). C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin. Immunol. 90, 247-255.
38. Saadoun, D., Sadallah, S., Trendelenburg, M., Limal, N., Sene, D., Piette, J. C., et al. (2006). Anti-C1q antibodies in hepatitis C virus infection. Clin. Exp. Immunol. 145, 308-312.
39. Schaller, M., Bigler, C., Danner, D., Ditzel, H. J., and Trendelenburg, M. (2009). Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven. J. Immunol. 183, 8225-8231.
40. Seelen, M. A., Trouw, L. A., and Daha, M. R. (2003). Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr. Opin. Nephrol. Hypertens. 12, 619-624.
41. Siegert, C. E., Daha, M. R., Halma, C., van der Voort, E. A., and Breedveld, F. C. (1992a). IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 10, 19-23.
42. Siegert, C. E., Daha, M. R., Lobatto, S., van der Voort, E. A., and Breedveld, F. C. (1992b). IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus. Immunol. Res. 11, 91-97.
43. Siegert, C. E., Daha, M. R., Swaak, A. J., van der Voort, E. A., and Breedveld, F. C. (1993). The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 67, 204-209.
44. Sinico, R. A., Rimoldi, L., Radice, A., Bianchi, L., Gallelli, B., and Moroni, G. (2009). Anti-C1q autoantibodies in lupus nephritis. Ann. N. Y. Acad. Sci. 1173, 47-51.
45. Stinton, L. M., Barr, S. G., Tibbles, L. A., Yilmaz, S., Sar, A., Benedikttson, H., et al. (2007). Autoantibodies in lupus nephritis patients requiring renal transplantation. Lupus 16, 394-400.
46. Stohl, W., and Hilbert, D. M. (2012). The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat. Biotechnol. 30, 69-77.
47. Trendelenburg, M. (2005). Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin. Immunopathol. 27, 276-285.
48. Trendelenburg, M., Lopez-Trascasa, M., Potlukova, E., Moll, S., Regenass, S., Fremeaux-Bacchi, V., et al. (2006). High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol. Dial. Transplant. 21, 3115-3121.
49. Trendelenburg, M., Marfurt, J., Gerber, I., Tyndall, A., and Schifferli, J. A. (1999). Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum. 42, 187-188.
50. Trouw, L. A., Bengtsson, A. A., Gelderman, K. A., Dahlback, B., Sturfelt, G., and Blom, A. M. (2007). C4b-binding protein and factor H compensate for the loss of membrane bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 282, 28540-28548.
51. Trouw, L. A., Blom, A. M., and Gasque, P. (2008). Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 45, 1199-1207.
52. Trouw, L. A., Groeneveld, T. W., Seelen, M. A., Duijs, J. M., Bajema, I. M., Prins, F. A., et al. (2004a). Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114, 679-688.
53. Trouw, L. A., Seelen, M. A., Visseren, R., Duijs, J. M., Benediktsson, H., de Heer, E., et al. (2004b). Anti-C1q autoantibodies in murine lupus nephritis. Clin. Exp. Immunol. 135, 41-48.
54. Trouw, L. A., Roos, A., and Daha, M. R. (2001). Autoantibodies to complement components. Mol. Immunol. 38, 199-206.
55. Trouw, L. A., Seelen, M. A., Duijs, J. M., Benediktsson, H., van Kooten, C., and Daha, M. R. (2003). Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin. Exp. Immunol. 132, 32-39.
56. Tsacheva, I., Radanova, M., Todorova, N., Argirova, T., and Kishore, U. (2007). Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Mol. Immunol. 44, 2147-2151.
57. Uwatoko, S., Aotsuka, S., Okawa, M., Egusa, Y., Yokohari, R., Aizawa, C., et al. (1984). Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 30, 104-116.
58. Uwatoko, S., Aotsuka, S., Okawa, M., Egusa, Y., Yokohari, R., Aizawa, C., et al. (1987). C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 69, 98-106.
59. Uwatoko, S., Gauthier, V. J., and Mannik, M. (1991). Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin. Immunol. Immunopathol. 61, 268-273.
60. Vanhecke, D., Roumenina, L. T., Wan, H., Osthoff, M., Schaller, M., and Trendelenburg, M. (2012). Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis Rheum. 64, 3706-3714.
61. Wener, M. H., Mannik, M., Schwartz, M. M., and Lewis, E. J. (1987). Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) 66, 85-97.
62. Wener, M. H., Uwatoko, S., and Mannik, M. (1989). Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 32, 544-551.
63. Wisnieski, J. J., and Jones, S. M. (1992). Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J. Immunol. 148, 1396-1403.
64. Yang, X. W., Tan, Y., Yu, F., and Zhao, M. H. (2012). Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol. Dial. Transplant. 27, 3552-3559.
65. Yin, Y., Wu, X., Shan, G., and Zhang, X. (2012). Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Lupus 21, 1088-1097.
66. Zhang, C. Q., Ren, L., Gao, F., Mu, F. Y., You, Y. Q., and Liu, Y. H. (2011). Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin. Rheumatol. 30, 967-973.